Prothena (PRTA) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PRTA Stock Alerts $21.34 -0.66 (-3.00%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Prothena Short Interest DataCurrent Short Volume6,750,000 sharesPrevious Short Volume6,630,000 sharesChange Vs. Previous Month+1.81%Dollar Volume Sold Short$137.30 millionShort Interest Ratio / Days to Cover11.1Last Record DateApril 30, 2024Outstanding Shares53,770,000 sharesPercentage of Shares Shorted12.55%Today's Trading Volume454,300 sharesAverage Trading Volume730,516 sharesToday's Volume Vs. Average62% Short Selling Prothena ? Sign up to receive the latest short interest report for Prothena and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRTA Short Interest Over TimePRTA Days to Cover Over TimePRTA Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Prothena Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,750,000 shares $137.30 million +1.8%N/A11.1 $20.34 4/15/20246,630,000 shares $145.79 million +2.5%N/A10.1 $21.99 3/31/20246,470,000 shares $160.26 million +3.5%N/A8.1 $24.77 3/15/20246,250,000 shares $162.94 million +3.0%N/A7.6 $26.07 2/29/20246,070,000 shares $167.47 million +4.5%N/A7 $27.59 2/15/20245,810,000 shares $165.70 million +1.0%N/A6.6 $28.52 Get the Latest News and Ratings for PRTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,750,000 shares $163.24 million -8.2%N/A6.8 $28.39 1/15/20246,260,000 shares $217.03 million +3.0%N/A7 $34.67 12/31/20236,080,000 shares $220.95 million +4.5%N/A6.8 $36.34 12/15/20235,820,000 shares $232.74 million -15.0%N/A7.6 $39.99 11/30/20236,850,000 shares $223.17 million +10.7%N/A10.1 $32.58 11/15/20236,190,000 shares $217.15 million -4.8%N/A9.6 $35.08 10/31/20236,500,000 shares $236.99 million +28.0%N/A10.6 $36.46 10/15/20235,080,000 shares $223.93 million +15.7%N/A10.4 $44.08 9/30/20234,390,000 shares $211.82 million +2.6%N/A10.7 $48.25 9/15/20234,280,000 shares $224.53 million +3.9%N/A11.2 $52.46 8/31/20234,120,000 shares $217.62 million +11.4%N/A10.6 $52.82 8/15/20233,700,000 shares $223.33 million +0.8%N/A9.4 $60.36 7/31/20233,670,000 shares $252.75 million +0.8%N/A9 $68.87 7/15/20233,640,000 shares $254.84 million +3.4%N/A8.3 $70.01 6/30/20233,520,000 shares $240.35 million -4.4%N/A7.9 $68.28 6/15/20233,680,000 shares $267.06 million +10.8%N/A7.8 $72.57 5/31/20233,320,000 shares $220.55 million +3.4%N/A7.1 $66.43 5/15/20233,210,000 shares $240.65 million -1.8%N/A6.7 $74.97 4/30/20233,270,000 shares $172.07 million No ChangeN/A6.9 $52.62 4/15/20233,270,000 shares $164.91 million -11.9%N/A7.5 $50.43 3/31/20233,710,000 shares $179.82 million +7.5%N/A8.3 $48.47 3/15/20233,450,000 shares $169.15 million +11.7%N/A6.9 $49.03 2/28/20233,090,000 shares $172.30 million +4.4%N/A5.9 $55.76 2/15/20232,960,000 shares $159.60 million +6.5%N/A5.6 $53.92 1/31/20232,780,000 shares $157.21 million -3.5%N/A5 $56.55 1/15/20232,880,000 shares $163.87 million +9.1%N/A5 $56.90 12/30/20222,640,000 shares $159.06 million +9.5%N/A4.4 $60.25 12/15/20222,410,000 shares $141.03 million +6.6%N/A2.9 $58.52 11/30/20222,260,000 shares $141.27 million +1.4%N/A2.7 $62.51 11/15/20222,230,000 shares $138.64 million -8.2%N/A2.7 $62.17 10/31/20222,430,000 shares $149.30 million -10.7%N/A3.1 $61.44 10/15/20222,720,000 shares $149.19 million -16.6%6.2%3.7 $54.85 9/30/20223,260,000 shares $197.65 million +32.5%7.4%4.8 $60.63 9/15/20222,460,000 shares $73.80 million -8.2%5.6%6.5 $30.00The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. PRTA Short Interest - Frequently Asked Questions What is Prothena's current short interest? Short interest is the volume of Prothena shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,750,000 shares of PRTA short. Learn More on Prothena's current short interest. What is a good short interest ratio for Prothena? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRTA shares currently have a short interest ratio of 11.0. Learn More on Prothena's short interest ratio. Is Prothena's short interest increasing or decreasing? Prothena saw a increase in short interest in April. As of April 30th, there was short interest totaling 6,750,000 shares, an increase of 1.8% from the previous total of 6,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Prothena's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Prothena: Gyre Therapeutics, Inc. (0.54%), Belite Bio, Inc (0.06%), Ironwood Pharmaceuticals, Inc. (13.04%), Spyre Therapeutics, Inc. (12.81%), Pacira BioSciences, Inc. (7.73%), Ligand Pharmaceuticals Incorporated (4.43%), Mirum Pharmaceuticals, Inc. (18.04%), Collegium Pharmaceutical, Inc. (21.78%), MannKind Co. (13.13%), Verona Pharma plc (7.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Prothena stock? Short selling PRTA is an investing strategy that aims to generate trading profit from Prothena as its price is falling. PRTA shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Prothena? A short squeeze for Prothena occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTA, which in turn drives the price of the stock up even further. How often is Prothena's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Gyre Therapeutics Short Squeeze Belite Bio Short Squeeze Ironwood Pharmaceuticals Short Squeeze Spyre Therapeutics Short Squeeze Pacira BioSciences Short Squeeze Ligand Pharmaceuticals Short Squeeze Mirum Pharmaceuticals Short Squeeze Collegium Pharmaceutical Short Squeeze MannKind Short Squeeze Verona Pharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss Ratings